amifostine anhydrous has been researched along with Bone Loss, Osteoclastic in 10 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dexrazoxane (DXR) is an iron-binding compound and the only approved cardioprotectant for use with DOX." | 1.33 | Amifostine and dexrazoxane enhance the rapid loss of bone mass and further deterioration of vertebrae architecture in female rats. ( Antoniou, J; Chalifour, LE; Ciobanu, I; Demers, CN; Héon, S; Mwale, F; Servant, N, 2005) |
| "PTHrP-(1-34) (90 pmol/h) stimulated bone resorption as evaluated by an increment in fasting urinary Ca excretion." | 1.28 | Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats. ( Bonjour, JP; Caverzasio, J; Chapuy, MC; Martin, TJ; Rizzoli, R, 1989) |
| " Chronic administration of WR-2721 (20 mg = 0." | 1.27 | Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721. ( Bonjour, JP; Caverzasio, J; Charhon, S; Hirschel-Scholz, S; Paunier, L; Rizzoli, R, 1988) |
| "In vitro bone resorption assays utilizing fetal rat long bones in organ culture showed complementary results." | 1.27 | In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat. ( Fallon, M; Goldfarb, S; Walker, ST; Weiss, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mwale, F | 1 |
| Ciobanu, I | 1 |
| Demers, CN | 1 |
| Antoniou, J | 1 |
| Héon, S | 1 |
| Servant, N | 1 |
| Chalifour, LE | 1 |
| Rizzoli, R | 4 |
| Bonjour, JP | 5 |
| Caverzasio, J | 4 |
| Chapuy, MC | 1 |
| Martin, TJ | 1 |
| Shaker, JL | 1 |
| Fallon, MD | 2 |
| Goldfarb, S | 3 |
| Farber, J | 1 |
| Attie, MF | 2 |
| Hirschel-Scholz, S | 3 |
| Charhon, S | 1 |
| Paunier, L | 1 |
| Spar, B | 1 |
| Wolf, JS | 1 |
| Slatopolsky, E | 1 |
| Warrell, RP | 1 |
| Weiss, J | 1 |
| Walker, ST | 1 |
| Fallon, M | 1 |
3 reviews available for amifostine anhydrous and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
[PTH-like tumor peptide and malignant hypercalcemia].
Topics: Amifostine; Bone Resorption; Calcium; Humans; Hypercalcemia; Neoplasm Proteins; Neoplasms; Parathyro | 1989 |
Management of hypercalcemia in relation to pathophysiology.
Topics: Amifostine; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Organothiophosph | 1987 |
Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism.
Topics: Amifostine; Animals; Bone Resorption; Humans; Hypercalcemia; Hyperparathyroidism; Magnesium; Organot | 1986 |
7 other studies available for amifostine anhydrous and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Amifostine and dexrazoxane enhance the rapid loss of bone mass and further deterioration of vertebrae architecture in female rats.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Bone Density; Bone Resorption; Cardiovascular Agen | 2005 |
Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Hypercalcemia; Kidney; Magnesium; Male; Metabolic Cle | 1989 |
WR-2721 reduces bone loss after hindlimb tenotomy in rats.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Data Interpretation, Statistical; Disease Models, Ani | 1989 |
Protection from progressive renal failure and hyperparathyroid bone remodeling by WR-2721.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Hyperparathyroidism, Secondary; Kidney Failure, Chron | 1988 |
Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino)ethylphosphorothioic acid. Studies in experimental animals and cultured bone cells.
Topics: Amifostine; Animals; Bone and Bones; Bone Resorption; Calcium; Calcium Radioisotopes; Cells, Culture | 1985 |
New inhibitors of osteolysis: implications for hypercalcemia and bone metastases.
Topics: Amifostine; Bone Neoplasms; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; | 1986 |
In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
Topics: Amifostine; Animals; Bone Resorption; Calcitriol; Carcinoma 256, Walker; Female; Glutathione; Hyperc | 1986 |